J&J shares nosedive after CDC announcement that its COVID vaccine CAN cause blood clots: Americans are advised against the shot and told to get Pfizer or Moderna...
The announcement sent the company's shares down by $173 to $168 at opening bell on Monday - a drop of 2.8 percent. J&J's one-shot vaccine was popular in March and April.
